[HTML][HTML] Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria
Malaria is one of the prevalent tropical diseases caused by the parasitic protozoan of the
genus Plasmodium spp. With an estimated 228 million cases, it is a major public health …
genus Plasmodium spp. With an estimated 228 million cases, it is a major public health …
Innovating Leishmaniasis Treatment: A Critical Chemist's Review of Inorganic Nanomaterials
IAA Bessa, DL D'Amato, AB C. Souza… - ACS Infectious …, 2024 - ACS Publications
Leishmaniasis, a critical Neglected Tropical Disease caused by Leishmania protozoa,
represents a significant global health risk, particularly in resource-limited regions …
represents a significant global health risk, particularly in resource-limited regions …
Triple-smart eco-friendly chili anthracnose control agro-nanocarrier
Pesticide leaching and soil contamination are major issues in the present agriculture
formulations. Hence, here 2D graphene oxide in combination with cationic, anionic, or …
formulations. Hence, here 2D graphene oxide in combination with cationic, anionic, or …
Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system
Herein, carboxymethyl chitosan (CMC) grafted lipid nanoformulations were facilely prepared
by thin-film hydration method as a highly efficient biocompatible anti-leishmanial carrier …
by thin-film hydration method as a highly efficient biocompatible anti-leishmanial carrier …
Coalition of biological agent (melatonin) with chemotherapeutic agent (amphotericin B) for combating visceral leishmaniasis via oral administration of modified solid …
In this study, 2-hydroxypropyl-β-cyclodextrin (HPβCD) grafted solid lipid nanoparticle (SLN)-
based bioconjugate was synthesized and used for administering a combination of melatonin …
based bioconjugate was synthesized and used for administering a combination of melatonin …
Hijacking the intrinsic vitamin B 12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity
Surface-functionalized vitamin B12 (VB12) biocompatible nanoparticles exploit the well-
characterized uptake pathway of VB12, shielding it from enzymatic degradation and …
characterized uptake pathway of VB12, shielding it from enzymatic degradation and …
Advances in nanotechnology for improving the targeted delivery and activity of amphotericin B (2011–2023): a systematic review
T Zadeh Mehrizi, N Mosaffa, M Vodjgani… - …, 2024 - Taylor & Francis
Amphotericin B (AmB) is a broad-spectrum therapeutic and effective drug, but it has serious
side effects of toxicity and solubility. Therefore, reducing its toxicity should be considered in …
side effects of toxicity and solubility. Therefore, reducing its toxicity should be considered in …
Development of Amphotericin B Decorated Gold Nanoparticles as a Promising Antileishmanial Nanoconjugate
K Sharma, J Shah, S Singh… - ACS Applied Bio …, 2024 - ACS Publications
Leishmaniasis, attributed to the protozoan parasite Leishmania, manifests in diverse clinical
forms, including cutaneous, mucocutaneous, and visceral leishmaniasis; VL constitutes a …
forms, including cutaneous, mucocutaneous, and visceral leishmaniasis; VL constitutes a …
Where do we stand? Insight on patented products and those under clinical trials
NA Lashgari, NM Roudsari, HS Shamsnia… - … Therapies and Drug …, 2024 - Elsevier
There are many different reasons that motivate the scientific community to discover new
drugs. From the industrial point of view, drugs with high absorption, potent effect, long half …
drugs. From the industrial point of view, drugs with high absorption, potent effect, long half …
Current Challenges and Nanotechnology-Based Pharmaceutical Approaches for the Treatment and Control of Visceral Leishmaniasis
G Yadagiri, SL Mudavath - Recent Advances in Pharmaceutical Innovation …, 2023 - Springer
Leishmaniasis, a neglected tropical disease (NTD), is caused by a kinetoplastid protozoan
parasite Leishmania. Visceral leishmaniasis (VL) is a significant public health concern, with …
parasite Leishmania. Visceral leishmaniasis (VL) is a significant public health concern, with …